Terminated trial tests new prep for 'Living Drug' against tough lymphoma
Disease control
Terminated
This study aimed to see if adding a new drug (ALLO-647) to the standard preparation regimen before a CAR T-cell therapy (ALLO-501A) was more effective for adults with large B-cell lymphoma that has returned or not responded to prior treatments. It compared the new combination aga…
Phase: PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC